Putnam Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $7.9M | Buy |
153,936
+33,024
| +27% | +$1.73M | 0.01% | 365 |
|
|
2023
Q3 | $7.02M | Sell |
120,912
-296,462
| -71% | -$18.2M | 0.01% | 375 |
|
|
2023
Q2 | $26.7M | Sell |
417,374
-18,181
| -4% | -$1.22M | 0.04% | 179 |
|
|
2023
Q1 | $30.2M | Sell |
435,555
-20,818
| -5% | -$1.47M | 0.05% | 174 |
|
|
2022
Q4 | $32.8M | Sell |
456,373
-4,946
| -1% | -$373K | 0.06% | 165 |
|
|
2022
Q3 | $32.8M | Sell |
461,319
-1,547
| -0.3% | -$112K | 0.06% | 163 |
|
|
2022
Q2 | $35.6M | Buy |
462,866
+196,365
| +74% | +$15M | 0.06% | 163 |
|
|
2022
Q1 | $19.5M | Sell |
266,501
-1,158,133
| -81% | -$77.8M | 0.03% | 227 |
|
|
2021
Q4 | $88.8M | Buy |
1,424,634
+97,775
| +7% | +$5.74M | 0.13% | 131 |
|
|
2021
Q3 | $78.5M | Sell |
1,326,859
-502,260
| -27% | -$33.1M | 0.12% | 144 |
|
|
2021
Q2 | $122M | Buy |
1,829,119
+53,327
| +3% | +$3.48M | 0.19% | 118 |
|
|
2021
Q1 | $112M | Buy |
1,775,792
+409,974
| +30% | +$25.5M | 0.19% | 119 |
|
|
2020
Q4 | $84.7M | Buy |
1,365,818
+325,679
| +31% | +$20M | 0.15% | 135 |
|
|
2020
Q3 | $62.7M | Sell |
1,040,139
-128,609
| -11% | -$7.74M | 0.12% | 146 |
|
|
2020
Q2 | $68.7M | Buy |
1,168,748
+270,655
| +30% | +$16.2M | 0.15% | 126 |
|
|
2020
Q1 | $50.1M | Sell |
898,093
-299,789
| -25% | -$18.3M | 0.13% | 144 |
|
|
2019
Q4 | $76.9M | Buy |
1,197,882
+457,824
| +62% | +$26.2M | 0.16% | 137 |
|
|
2019
Q3 | $37.5M | Sell |
740,058
-107,724
| -13% | -$5.06M | 0.08% | 195 |
|
|
2019
Q2 | $38.4M | Sell |
847,782
-464,489
| -35% | -$21.6M | 0.09% | 191 |
|
|
2019
Q1 | $62.6M | Buy |
1,312,271
+957,482
| +270% | +$47.7M | 0.15% | 146 |
|
|
2018
Q4 | $18.4M | Sell |
354,789
-1,242,207
| -78% | -$66.7M | 0.05% | 235 |
|
|
2018
Q3 | $99.1M | Sell |
1,596,996
-112,481
| -7% | -$6.68M | 0.21% | 124 |
|
|
2018
Q2 | $94.6M | Sell |
1,709,477
-1,011,883
| -37% | -$54.6M | 0.22% | 124 |
|
|
2018
Q1 | $172M | Buy |
2,721,360
+1,642,115
| +152% | +$106M | 0.4% | 68 |
|
|
2017
Q4 | $66.1M | Buy |
1,079,245
+579,158
| +116% | +$36.2M | 0.15% | 151 |
|
|
2017
Q3 | $31.9M | Sell |
500,087
-387,734
| -44% | -$22.6M | 0.07% | 210 |
|
|
2017
Q2 | $49.5M | Sell |
887,821
-730,719
| -45% | -$39.8M | 0.12% | 160 |
|
|
2017
Q1 | $88M | Sell |
1,618,540
-783,697
| -33% | -$43M | 0.21% | 127 |
|
|
2016
Q4 | $140M | Sell |
2,402,237
-480,721
| -17% | -$26.3M | 0.34% | 82 |
|
|
2016
Q3 | $155M | Sell |
2,882,958
-86,457
| -3% | -$5.55M | 0.37% | 67 |
|
|
2016
Q2 | $218M | Sell |
2,969,415
-839,258
| -22% | -$59.3M | 0.53% | 49 |
|
|
2016
Q1 | $243M | Sell |
3,808,673
-371,650
| -9% | -$23.4M | 0.58% | 37 |
|
|
2015
Q4 | $288M | Buy |
4,180,323
+161,541
| +4% | +$10.7M | 0.65% | 33 |
|
|
2015
Q3 | $238M | Sell |
4,018,782
-87,619
| -2% | -$5.56M | 0.53% | 39 |
|
|
2015
Q2 | $273M | Buy |
4,106,401
+541,172
| +15% | +$35.7M | 0.55% | 38 |
|
|
2015
Q1 | $230M | Buy |
3,565,229
+674,678
| +23% | +$42.2M | 0.46% | 44 |
|
|
2014
Q4 | $171M | Sell |
2,890,551
-82,151
| -3% | -$4.63M | 0.35% | 68 |
|
|
2014
Q3 | $152M | Sell |
2,972,702
-452,433
| -13% | -$22.6M | 0.32% | 70 |
|
|
2014
Q2 | $166M | Buy |
3,425,135
+811,956
| +31% | +$40M | 0.36% | 71 |
|
|
2014
Q1 | $136M | Buy |
2,613,179
+2,194,016
| +523% | +$117M | 0.31% | 80 |
|
|
2013
Q4 | $22.3M | Sell |
419,163
-626,196
| -60% | -$31.9M | 0.05% | 311 |
|
|
2013
Q3 | $48.4M | Buy |
1,045,359
+73,198
| +8% | +$3.21M | 0.13% | 182 |
|
|
2013
Q2 | $43.4M | Buy |
+972,161
| New | +$42.2M | 0.13% | 189 |
|
Other funds holding BMY
Putnam Investments's BMY Position: Q4 2023 in Review
Putnam Investments increased its Bristol-Myers Squibb (BMY) stake by 27% in Q4 2023, buying an estimated $1.73M and bringing the position to 153,936 shares worth $7.9M. The position accounts for 0.01% of the portfolio, ranked #365.
Putnam Investments first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. The position peaked at $288M in Q4 2015. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Putnam Investments held 153,936 shares of Bristol-Myers Squibb worth $7.9M as of Q4 2023.
- Putnam Investments bought 33,024 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.73M.
- Bristol-Myers Squibb made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #365 holding.
- Putnam Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Bristol-Myers Squibb position peaked at $288M in Q4 2015.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.